January 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreApril 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreJune 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreApril 21, 2026
According to market projections, the new chemical entities (NCE) CDMO sector is expected to grow from USD 2.65 billion in 2024 to USD 7.83 billion by 2034, reflecting a CAGR of 11.44%. The new chemical entities (NCE) CDMO market is growing due to its offering hope for managing diseases where existing therapies fall short or are inaccessible. North ...
April 21, 2026
Market insights predict, the Middle East and Africa clinical trials industry is expected to grow from USD 2.81 billion in 2025 to USD 5.79 billion by 2035, driven by a CAGR of 6.80%. The rising prevalence of chronic and lifestyle diseases such as diabetes, cardiovascular disorders, and cancer increases demand for new drugs and therapies has driven ...
April 21, 2026
Market insights predict the global Latin America pharmaceutical industry will increase from USD 91.85 billion in 2024 to USD 172.71 billion by 2034, achieving a CAGR of 6.52%. The market is expanding due to the rising prevalence of chronic diseases, increasing healthcare expenditure, and growing demand for innovative therapies. In Latin America, Br...
April 21, 2026
According to forecasts, the global myasthenia gravis treatment market will grow from USD 1.55 billion in 2024 to USD 3.29 billion by 2034, with an expected CAGR of 7.84%. The myasthenia gravis treatment market is growing due to the rising prevalence of myasthenia gravis (MG), the growing aging population, and enhanced diagnostic abilities. North Am...
April 21, 2026
The cell and gene therapy infrastructure market is growing due to advances in gene editing technology and the increasing prevalence of genetic and chronic diseases. North America is dominant in the market due to the robust public and private spending....
April 21, 2026
Market insights predict the Europe clinical trials industry will increase from USD 11.65 billion in 2025 to USD 21.73 billion by 2035, achieving a CAGR of 4.80%. The Europe clinical trials market is expanding due to stringent regulations as well as growing innovations....
April 21, 2026
The AI-based pharmaceutical R&D services market is growing due to rising demand for automation. North America’s dominance can be attributed to the rising R&D in developing novel therapeutics....
April 21, 2026
Market insights predict, the Latin America clinical trials industry is expected to grow from USD 4.67 billion in 2025 to USD 9.17 billion by 2035, driven by a CAGR of 6.30%%. The tremendous advantages of clinical research for pharmaceutical and biotechnology companies in meeting public health needs drive the need for clinical trials. Latin America ...
April 21, 2026
Market insights predict the APAC clinical trials industry will increase from USD 18.87 billion in 2025 to USD 41.33 billion by 2035, achieving a CAGR of 7.16%. The market is growing due to the increasing demand for new and effective therapies and rising R&D investments. In the Asia Pacific region, rapid growth is driven by lower operational cos...
April 21, 2026
The inhaled therapy in respiratory disease market is valued at USD 11.98 billion in 2025 and expected to reach USD 16.22 billion by 2034 at 3.44% CAGR. Dominant segments include bronchodilators (28%), MDIs (35%), COPD (38%), retail pharmacies (60%), and inhaled biologics growing fastest. North America holds 42% share, Asia Pacific fastest-growing. ...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
